美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Invesco Nasdaq Biotechnology ETF

33.43

-0.8148-2.38%

盘后：33.440.0066+0.02%19:30 EDT

成交量：4.33万

成交额：145.21万

市值：1.08亿

市盈率：- -

高：34.02

开：34.02

低：33.43

收：34.25

52周最高：36.84

52周最低：25.00

股本：322.00万

流通股本：322.00万

量比：0.99

换手率：1.34%

股息：0.39

股息率：1.17%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会在京顺利举行！

福泰制药(VRTX)股票10月13日盘中下跌3.13%：投资者必看的核心信息

TradingKey中文

长春高新：关于子公司GenSci161注射液境内生产药品注册临床试验申请获得受理的公告

长春高新：子公司GenSci161注射液临床试验申请获受理

悦康药业：子公司YKYY036注射液获中美临床试验批准

强生(JNJ.US)Q3盈利超预期并上调全年业绩指引！创新药业务放量器械业务仍待改善

利润说了算！创新药板块新旧交替，谁会在未来更赚钱？

东方财富网

数据简报-大型制药企业纷纷转向中国寻求许可协议

恒瑞医药(600276.SH)：SHR-3201注射液获得药物临床试验批准通知书

恒瑞医药：SHR-3201注射液获临床试验批准

科济药业：CT0596在中国I期注册临床试验中完成首例患者输注

港股创新药概念股集体走低，华昊中天医药-B跌超11%、金斯瑞生物科技跌超10%

老虎资讯综合

辛达克斯制药特发性肺纤维化临床试验失败，盘后股价暴跌34%。

再生元制药：Pasatru在第56至84周展现出持续疗效与一致性安全性

博瑞医药(688166.SH)：BGM0504片获得药物临床试验批准通知书

微芯生物(688321.SH)：CS43158片获得药物临床试验批准通知书

神州细胞：控股子公司SCT810注射液获临床试验批准

纳微科技与智翔金泰签署战略合作协议

神州细胞：控股子公司SCT810注射液获临床试验批准

微芯生物：CS43158片获得药物临床试验批准通知书

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/IBBQ/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":33.4334,"timestamp":1791921600000,"preClose":34.2482,"halted":0,"volume":43277,"hourTrading":{"tag":"盘后","latestPrice":33.44,"preClose":33.4334,"latestTime":"19:30 EDT","volume":143,"amount":4820.2502,"timestamp":1791934204007,"change":0.0066,"changeRate":0.000197,"amplitude":0},"delay":0,"changeRate":-0.02379103135347254,"floatShares":3220001,"shares":3220001,"eps":0,"marketStatus":"已收盘","change":-0.8148,"latestTime":"10-13 16:00:00 EDT","open":34.02,"high":34.02,"low":33.4334,"amount":1452145.02082,"amplitude":0.017128,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":34.2482,"sharesOutstanding":2520001,"nav":34.23493,"aum":110578858.13493,"dividendRate":0.011701,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.44,"preClose":33.4334,"latestTime":"19:30 EDT","volume":143,"amount":4820.2502,"timestamp":1791934204007,"change":0.0066,"changeRate":0.000197,"amplitude":0},"volumeRatio":0.993512,"impliedVol":0.1579,"impliedVolPercentile":0.6653},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3220001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.993512,"shares":3220001,"dividePrice":0.3912,"high":34.02,"amplitude":0.017128,"preClose":34.2482,"low":33.4334,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":33.4334,"eps":0,"divideRate":0.011701,"volume":43277,"delay":0,"ttmEps":0,"open":34.02,"prevYearClose":28.3962,"prevWeekClose":34.62,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":33.9,"twentyDayClose":34.25,"sixtyDayClose":32.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675399655","title":"盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会在京顺利举行！","url":"https://stock-news.laohu8.com/highlight/detail?id=2675399655","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675399655?lang=zh_cn&edition=fundamental","pubTime":"2026-10-14 09:10","pubTimestamp":1791940201,"startTime":"0","endTime":"0","summary":"10月13日，盘龙药业“盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会”于北京经济技术开发区(亦庄)举行。随着北京盘龙健康智创中心正式启新，盘龙药业“西安+北京”双总部格局浮出水面，运行多年的“一体两翼三纵深”战略也由此打开全新维度。本次北京盘龙健康智创中心的设立，正是“一体两翼三纵深”战略在研发纵深、营销纵深两大板块的关键落子。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/14/20261014982848.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/14/20261014982848.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261014/32395999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","IBBQ","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675136687","title":"福泰制药(VRTX)股票10月13日盘中下跌3.13%：投资者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2675136687","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675136687?lang=zh_cn&edition=fundamental","pubTime":"2026-10-14 00:15","pubTimestamp":1791908152,"startTime":"0","endTime":"0","summary":"• 受生物科技板块走弱与技术性卖压影响，福泰制药面临股价下行压力。\n• 囊性纤维化领域的领先地位及管线多元化持续支撑其核心基本面。\n• 技术指标显示 MACD 卖出信号和威廉指标（Williams %R）超卖状态。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262214484-market-movers-vrtx-20261013","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4585","BIB","SG9999001176.USD","LU1674673428.USD","IE0002270589.USD","IE00B2B36J28.USD","BK4139","IE00B19Z3B42.SGD","LU2089984988.USD","LU2468319806.SGD","LU0058720904.USD","LU0320765992.SGD","LU0256863811.USD","IDNA","IBB","LU0823416689.USD","LU0889565916.HKD","SG9999013999.USD","GNMX","LU1069344957.HKD","IBBQ","LU0234570918.USD","VRTX","TBXU","LU2324357040.USD","BK4567","LU0417517546.SGD","BK4533","LU2237438978.USD","LU2362541513.USD","LU0079474960.USD","BBH","LU1093756325.SGD","SGXZ57979304.SGD","IE00B894F039.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU2236285917.USD","LU2417539215.USD","IE00B19Z9P08.USD","LU1035775433.USD","LU2362540622.SGD","LU1430594728.SGD","LU1585245621.USD","IE00BFTCPJ56.SGD","PBE","LU1093756168.USD","IE0009355771.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675357355","title":"长春高新：关于子公司GenSci161注射液境内生产药品注册临床试验申请获得受理的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2675357355","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675357355?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 21:09","pubTimestamp":1791896940,"startTime":"0","endTime":"0","summary":"    证券日报网讯 10月13日，长春高新发布公告称，公司控股子公司长春金赛药业有限责任公司近日收到国家药品监督管理局核准签发的《受理通知书》，金赛药业GenSci ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261013/c680653921.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261013/c680653921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0239","BK0075","BK0057","IBBJ","MDTX","BK0028","000661","BK0188","BK0046","BMED","IBBQ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675355429","title":"长春高新：子公司GenSci161注射液临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2675355429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675355429?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 18:58","pubTimestamp":1791889081,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PSYK","BMED","IBBJ","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675935636","title":"悦康药业：子公司YKYY036注射液获中美临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2675935636","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675935636?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 18:55","pubTimestamp":1791888900,"startTime":"0","endTime":"0","summary":"10月13日，悦康药业(688658.SH)公告称，公司子公司北京悦康科创医药科技股份有限公司、悦康药业集团杭州天龙药业有限公司的YKYY036注射液(适应症为肥胖或超重)，近日获得国家药监局临床试验 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261013/c680648649.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261013/c680648649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BMED","688658","MDTX","BK0239","IBBJ","IBBQ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675535534","title":"强生(JNJ.US)Q3盈利超预期并上调全年业绩指引！创新药业务放量 器械业务仍待改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2675535534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675535534?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 18:43","pubTimestamp":1791888206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0072461881.USD","LU1032466523.USD","LU1228905037.USD","LU0162691827.USD","IBBQ","LU1221951129.SGD","LU1894683264.USD","LU2750360997.AUD","VHT","TRUH","JDOC","SG9999002232.USD","LU0289739343.SGD","BMED","IHE","SG9999001440.SGD","IE00BVYPNV92.GBP","FHLC","BK4533","BK4532","LU2023250330.USD","GDOC","SG9999001176.USD","LNGR","LU0058720904.USD","LU0124676726.USD","ZECP","SG9999002224.SGD","LU0964807845.USD","LU0114720955.EUR","IE00B19Z3581.USD","IE00B2B36J28.USD","JNJ","LU0466842654.USD","LU1674673691.USD","IYH","RXL","FTXH","LU0098860793.USD","IXJ","XLV","IE00B1BXHZ80.USD","PJP","LU0661504455.SGD","MEDX","LU1674673428.USD","LU1228905540.USD","LU0553294199.USD","IE000MB6IJN5.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675933070","title":"利润说了算！创新药板块新旧交替，谁会在未来更赚钱？","url":"https://stock-news.laohu8.com/highlight/detail?id=2675933070","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675933070?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 17:47","pubTimestamp":1791884825,"startTime":"0","endTime":"0","summary":"近期，CS创新药（中证指数，931152.CSI）半山腰上徘徊不定，截至9月12日，近一个月上涨3.18%。其中，昭衍新药（603127.SH）上涨22.63%，艾力斯（688578.SH）下跌22.46%，出现了表现几乎完全对称相反的两只个股，市场资金在如何投票？长尾企业占比九成，头部格局依旧“固化”，创新药板块可能正经历一场深刻的新旧动能转换。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202610133894240865.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202610133894240865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["IBBQ","BK1574","LNGR","MEDX","159992","BK1161","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675337610","title":"数据简报-大型制药企业纷纷转向中国寻求许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2675337610","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675337610?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 17:24","pubTimestamp":1791883476,"startTime":"0","endTime":"0","summary":"数据简报-大型制药企业纷纷转向中国寻求许可协议更新发稿日期，重写导语并补充罗氏与罗纳治疗公司达成协议的内容路透10月13日-罗纳治疗公司周二表示，已与瑞士制药商罗氏签署了一项价值高达11.6亿美元的许可协议ROPC.S，涉及一种实验性减肥药物候选分子。这是中国生物技术公司与全球制药商之间一波交易中的最新一例。中国生物技术公司通常保留国内权益 ，并将药物授权给海外企业，以此换取预付款、里程碑付款以及特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nL4T45Z0RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU0354030438.USD","LU0174119429.USD","LU1732799900.SGD","LU0306807586.USD","LU1267930573.SGD","03692","BK4568","LU1400636574.HKD","SGXZ31699556.SGD","IE00BPRC5H50.USD","LU0122379950.USD","LU1244550577.SGD","LU2237443465.HKD","BK4581","LU1328615791.USD","IE00BJJMRX11.SGD","LU1146622755.USD","LU1718418525.SGD","LU1236620834.HKD","LU2347655073.USD","LU0345770308.USD","LU0237698245.USD","LU0786609619.USD","IE0002270589.USD","LU0861579265.USD","BK0239","BK4548","LU2602419157.SGD","LU0683600562.USD","LU1003077747.HKD","BNTX","LLYX","LU2468319806.SGD","LU1400636491.USD","ABBV","LU0455707207.USD","LU0787776722.HKD","IE0009355771.USD","LU0348766576.USD","NVOX","LU1015430645.USD","LU1226288253.USD","LU2491050154.USD","IE00BLSP4452.SGD","LU0823434583.USD","HRTS","BK0196","LU1069344957.HKD","SGXZ99366536.SGD","BK4599","IE00BJJMRZ35.SGD","LU0708995401.HKD","IE00B3PB1722.GBP","LU0726765562.USD","IE0004445015.USD","BK4532","LU1226287875.USD","LU2097828805.USD","LU1712237335.SGD","01801","LU1244550221.USD","LU2039709279.SGD","IE00B19Z3581.USD","LU2112291526.USD","BK1588","BK4559","LU0114720955.EUR","BK0188","LU0315179316.USD","BK1589","LU0971552673.USD","LU1969619763.USD","LU1585245621.USD","LU2552382215.SGD","LU1093756168.USD","SG9999014542.SGD","BK4592","IE0004445239.USD","LU0057025933.USD","LU0501845795.SGD","LU2495084118.USD","LU2357627491.SGD","LU0640476718.USD","IE00B543WZ88.USD","NVOH","BK4516","SGXZ57979304.SGD","LU1670710588.SGD","LU0266013472.USD","IE00BZ08YT58.USD","LU2237443622.USD","BK1521","SG9999014898.SGD","LU1720051108.HKD","LU0320765489.SGD","LU0130102774.USD","LU0471298694.HKD","LU2778985437.USD","LU0820561909.HKD","LU2646069778.SGD","LU1309081286.SGD","LU1037948541.HKD","LU2108987350.USD","GSK.UK","LU0162691827.USD","SGXZ51526630.SGD","LU0203345920.USD","LU1074936037.SGD","LU2476274720.SGD","LU0463099449.HKD","LU2488822045.USD","LU0385154629.USD","LU0859254822.USD","LU1366192091.USD","LU1699723380.USD","LU2211815571.USD","LU2129689605.HKD","LU2750360997.AUD","IE000BZT7R73.USD","LU0949170772.SGD","LU1046248800.SGD","LU2023250330.USD","LU1934455863.HKD","SG9999015341.SGD","LU0094547139.USD","LU1670710661.SGD","LU1894683264.USD","LU0244354667.USD","LU1162221912.USD","LU2361044949.HKD","SG9999015945.SGD","LU0289739699.SGD","LU2360106947.USD","09995","SG9999014559.SGD","LLII","LU1127390331.HKD","LU0417516738.SGD","SG9999011175.SGD","LU2236285917.USD","LU0417516571.SGD","LU1255011170.USD","IE00B1XK9C88.USD","LU0432979614.USD","LU0912757837.SGD","LU2756315318.SGD","LU0211327993.USD","BK4588","IE00B031HY20.USD","LU1988902786.USD","SG9999015358.SGD","LU0471298777.SGD","BK1593","LU0106261372.USD","MEDI","IE00BZ1G4Q59.USD","LU0502904849.HKD","LU2111349929.HKD","LU0198837287.USD","IBBQ","LU1228905037.USD","CANC","LU0265550946.USD","LU0661504455.SGD","LU2129689514.USD","RXL","LU0511384066.AUD","SG9999015986.USD","LU0289739343.SGD","LU0965509283.SGD","SMMT","LU1244550494.USD","BK0183","LU0321505439.SGD","LU0133085943.USD","BK4550","LU1152091168.USD","LU1548497426.USD","LU0466842654.USD","LU0256863902.USD","LU1868837136.USD","LU0472753341.HKD","XLV","LU1868836757.USD","LU2148510915.USD","WDNA","IE00BVYPNV92.GBP","LU1328277881.USD","LU0097036916.USD","LU2471134796.USD","LU0985481810.HKD","IE00B7KXQ091.USD","01276","LU0158827781.USD","LU1261432733.SGD","LU1061106388.HKD","LU0965509101.SGD","BK1574","LU2347655156.SGD","LU1814569148.SGD","LU0154236417.USD","LU1236620750.USD","LU0109394709.USD","LU0306806265.USD","LU1291159041.SGD","IE00BN8TJ469.HKD","LU1960683339.HKD","LU2129689431.USD","MEDX","LU2552382058.USD","LU0310800379.SGD","BK0060","LU1934455277.USD","LU1280957306.USD","LU1064130708.USD","LU2168564222.USD","LU0069063385.USD","LU0211328371.USD","LLY","LU1997245177.USD","LU2399975544.HKD","LU1066051225.USD","LU1323610961.USD","LU1226288170.HKD","LLYZ","LU1629891620.HKD","IE00BGHQF631.EUR","SG9999001440.SGD","LU1997245094.SGD","LU0072461881.USD","LU0070302665.USD","LU1035777561.USD","LU1997244956.HKD","LU0211331839.USD","THNR","00013","LU1267930490.SGD","IE00B775H168.HKD","LU0417516902.SGD","LU2417539215.USD","LU2289578879.USD","SG9999002232.USD","LU2089283258.USD","GB00BDT5M118.USD","SG9999014567.USD","LU2491050071.SGD","LU0868494708.USD","LU2168564149.EUR","LU1496350171.SGD","BK4551","LU0234570918.USD","IE000M9KFDE8.USD","IE00BZ08YS42.EUR","LU0689472784.USD","AZN","LU2097828631.EUR","01093","LU0061475181.USD","LU2462591350.SGD","LU0942090050.USD","ILDR","LU1820825898.SGD","LU0557290698.USD","LU1226287792.SGD","LU1201861249.SGD","LU0477156953.USD","LU2237443895.HKD","SG9999014914.USD","LU0225771236.USD","IE00B2B36J28.USD","LU2362541273.HKD","IE00BVYPNW00.USD","LU0124676726.USD","LU1145028129.USD","TBXU","LU1400636657.SGD","LU2746668974.SGD","LU0943347566.SGD","LU1064131003.USD","LU1645745479.HKD","LU0553294199.USD","LU1066051811.HKD","01530","TMED","600276","IE00BFXG1179.USD","VHT","LU2461242641.AUD","LU0648001328.SGD","LU2125909247.SGD","LU0348825331.USD","LU2746668461.USD","LU1232071149.USD","IE00BKVL7J92.USD","LU0354030511.USD","IE00BJLML261.HKD","LU2491049909.HKD","LU0289961442.SGD","LU2471134879.HKD","IE0002141913.USD","LU2242652126.USD","LU1989772840.SGD","LU0561508036.HKD","LU2361044865.SGD","LU1941712264.USD","LU2264538146.SGD","LU2580892862.HKD","LU1496350502.SGD","LU1951186391.HKD","LU1691799644.USD","LU0820562030.AUD","SG9999004220.SGD","LU0672654240.SGD","LU0058720904.USD","LU0079474960.USD","LU0607220059.USD","LU2097828474.EUR","IE00BBT3K403.USD","LU1481599808.USD","LU0417517546.SGD","LU2237438978.USD","LU0208291251.USD","LU1720050803.USD","IE00B19Z3B42.SGD","LU1093756325.SGD","LU0210536198.USD","LU0234572021.USD","09926","LU2087625088.SGD","SG9999017495.SGD","GDOC","LU2324357040.USD","LU0238689110.USD","IE00BFSS7M15.SGD","LU1623119135.USD","LU2063271972.USD","IHE","LU0395794307.EUR","LU0096364046.USD","IE0001KFT4U8.USD","BK4535","LU1807302812.USD","BK4007","LU2023251221.USD","IE00B4R5TH58.HKD","LU2213496289.HKD","OZEM","TRUH","PAWZ","LU0405327494.USD","LU1008478684.HKD","HCM","BK4534","LU2106854487.HKD","SG9999001176.USD","IE00BN29S564.USD","LU1069347547.HKD","LU0326950275.SGD","IE000WAW04H5.SGD","LU0267386448.USD","AZNH","IE00B5MMRT66.SGD","IE0008369823.USD","688331","LU2133065610.SGD","LU0006306889.USD","LU1037948897.HKD","LU2237443978.SGD","LU1670756490.USD","LU1655091616.SGD","LU0170899867.USD","LU1032466523.USD","SG9999014575.USD","LU0348784397.USD","LU0987226296.USD","LU0161305163.EUR","LU1430594728.SGD","LU1813983027.USD","LU2089984988.USD","ELIS","LU2360032135.SGD","LU0540923850.HKD","LU1098665638.USD","LU0128525929.USD","IE00BWDBJ516.SGD","BMY","LU2580892789.USD","IE00BQJZX424.USD","LU0225283273.USD","LU0823434740.USD","LU0980610538.SGD","LU0072913022.USD","SGXZ81514606.USD","IE0034235071.USD","LU0029864427.USD","LU1267930730.SGD","LU0225284248.USD","NVOC","LU2023250843.SGD","LU2097828714.EUR","MRK","LU0348767384.USD","LU0130517989.USD","LU0320765059.SGD","SG9999003800.SGD","SG9999015952.SGD","LU0405327148.USD","LU1116320901.HKD","LU0823416689.USD","LU0149534421.HKD","LU0203202063.USD","BK1515","SG9999018857.SGD","LU0158827948.USD","LU1116320737.USD","IE00BZ08YR35.GBP","LU0345770993.USD","LU1571399168.USD","LU1989771016.USD","LU1066053197.SGD","LU2087621335.USD","SG9999018865.SGD","LU1923622614.USD","LU0348827113.USD","CURE","LU2471134523.USD","SG9999015978.USD","LU2362541513.USD","IE00B42XCP33.USD","LU2089284900.SGD","MHIP","IBB","LU0053666078.USD","BK4533","LU1670711123.USD","IE00BKPKM429.USD","LU1829250122.USD","LU2271345857.HKD","LU2125909593.SGD","LU2125154778.USD","IE000MB6IJN5.SGD","LU0575583348.USD","LU2237443382.USD","LU0882574055.USD","LU1670711040.USD","IE0008368742.USD","LU0971552830.HKD","LU1064131342.USD","LU0310799852.SGD","LU0109391861.USD","LU1035773651.USD","LU1066051498.USD","LU2265009873.SGD","LU0868494617.USD","IE00BK4W5M84.HKD","LU2357305700.SGD","LU2596442595.SGD","BBH","LU0203201768.USD","LU0889565916.HKD","SG9999013999.USD","LU1551013342.USD","LU1023059063.AUD","LU1868836914.USD","BK0012","LU2362540622.SGD","IE000SO60NU8.SGD","LU1202635105.USD","IE00BKDWB100.SGD","LU0348735423.USD","IE00BLSP4239.USD","LU1580142542.USD","IE00BJJMRY28.SGD","LU1226287529.USD","LU2168564065.EUR","LU0545562505.USD","LU2237443549.SGD","LU2125154935.USD","LU1883839398.USD","LU2750360641.GBP","LU1961090484.USD","LU1670628061.USD","LU2168564495.EUR","LU0353189763.USD","LU1868837300.USD","BK1583","LU1917777945.USD","LU1228905540.USD","LU0545039389.USD","LU0708994859.HKD","IE0000B7K699.USD","BK1587","LU2476274308.USD","LU2552382132.HKD","IE00BDGV0183.EUR","LU0965508806.USD","PFE","LU1839511570.USD","LU1868836591.USD","IE00BWXC8680.SGD","AGNG","LU1551013425.SGD","LU2242646821.SGD","IE00B3T34201.USD","FHLC","LU0882574139.USD","LU2242644610.SGD","IE0005OL40V9.USD","PPH","LU0456855351.SGD","NVO","LU0320765992.SGD","LU0203347892.USD","LU1989772923.USD","LU0738911758.USD","LU1983299246.USD","LU1993786604.SGD","LU0320765646.SGD","IE00B1BXHZ80.USD","LU0634319403.HKD","LU2462157665.USD","IE00BJT1NW94.SGD","REGN","LU0109981661.USD","IE00BK4W5L77.USD","LU1974910355.USD","LU1064927863.SGD","LU2023250504.SGD","SG9999002224.SGD","BK4585","LU1781817850.SGD","LU0323591593.USD","LU1941712348.USD","BMED","LU2168563687.JPY","SG9999001176.SGD","LU1720051017.SGD","LU1302929846.USD","LU2456880835.USD","LU0265550359.USD","LU0256863811.USD","LU0880133367.SGD","KURE","IE00B4JS1V06.HKD","LU0820561818.USD","LU1487256676.USD","LU1831875114.USD","IE000F7OJYX1.SGD","LU0795875086.SGD","LU2756315664.SGD","BK4139","PJP","LU0985320562.USD","LU0316494557.USD","LU1794554557.SGD","LU1057294990.SGD","LU0689626769.HKD","IE00BFSS8Q28.SGD","LU2896262040.SGD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1152091754.HKD","LU0795875169.SGD","LU0348783233.USD","LU1894683348.USD","LU1481600234.SGD","LU2471134952.CNY","LU0067412154.USD","LU1188198961.HKD","LU1670627923.USD","LU0314109678.HKD","LU0965509010.AUD","ELIL","LU0353189680.USD","BK1161","SG9999014880.SGD","BK0028","BK1191","LU1979441026.SGD","LU1732800096.USD","LU2028103732.USD","BK5011","IYH","LU2433249047.HKD","FTXH","LU0140636845.USD","GLAM","LU2328871848.SGD","SG9999014906.USD","JDOC","HK0000165453.HKD","LU2361045086.USD","LU1929549753.HKD","LU0964807845.USD","LU0321505868.SGD","LU1934455194.USD","IXJ","LU1804176565.USD","BK4566","LU2097828557.USD","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675332404","title":"恒瑞医药(600276.SH)：SHR-3201注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2675332404","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675332404?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 17:04","pubTimestamp":1791882254,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(600276.SH)发布公告，近日，公司子公司北京盛迪医药有限公司收到国家药品监督管理局核准签发关于SHR-3201注射液的《药物临床试验批准通知书》，将于近期开展临床试验。申请的适应症：阿尔茨海默病。SHR-3201注射液是公司自主研发治疗AD的药物，可清除患者脑内的疾病生物标志物，延缓患者认知衰退。经查询，国内外尚无同类药物获批上市。截至目前，SHR-3201注射液相关项目累计研发投入约为4,880万元(未经审计)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","LU2097828714.EUR","LU1255011170.USD","LU2580892862.HKD","LU2097828805.USD","BK0028","BK0188","LU1781817850.SGD","BK0196","BK1191","LU0359201612.USD","LU1580142542.USD","LU1997245177.USD","01276","MDTX","BK0183","BMED","LU0405327148.USD","LU1997245094.SGD","IBBJ","LU1023057109.AUD","LU1997244956.HKD","LU1328615791.USD","LU2097828631.EUR","LU2580892789.USD","BK0239","LU2148510915.USD","LU2097828474.EUR","BK0012","BK0060","LU1064130708.USD","LU2543165471.USD","LU0359201885.HKD","LU1146622755.USD","LU1820825898.SGD","LU1655091616.SGD","LU2097828557.USD","LU1064131003.USD","LU0359202008.SGD","LU2488822045.USD","LU1969619763.USD","600276","PSYK","LU0405327494.USD","LU2495084118.USD","LU2289578879.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675332534","title":"恒瑞医药：SHR-3201注射液获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2675332534","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675332534?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 16:58","pubTimestamp":1791881913,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PSYK","MDTX","IBBJ","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675382309","title":"科济药业：CT0596在中国I期注册临床试验中完成首例患者输注","url":"https://stock-news.laohu8.com/highlight/detail?id=2675382309","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675382309?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 11:02","pubTimestamp":1791860527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IBBQ","MDTX","IBBJ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157830362","title":"港股创新药概念股集体走低，华昊中天医药-B跌超11%、金斯瑞生物科技跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157830362","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157830362?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 09:38","pubTimestamp":1791855517,"startTime":"0","endTime":"0","summary":"10月13日，港股创新药概念股集体走低，$华昊中天医药-B(02563)$跌超11%，$金斯瑞生物科技(01548)$跌超10%，$药明合联(02268)$、$晶泰控股(02228)$跌超4%，$药明生物(02269)$、$歌礼制药-B(01672)$跌超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211977185.USD","SG9999002562.SGD","LU0359201612.USD","LU0561508036.HKD","LU0516422440.USD","LU0572944931.SGD","BK1161","LU0039217434.USD","MEDX","KURE","02268","HK0000320223.HKD","LU0244354667.USD","LU2778985437.USD","LU0819121731.USD","LNGR","BK1515","BK1574","LU0708995153.HKD","LU0516422366.SGD","BK4588","LU0326950275.SGD","LU1831875114.USD","LU0823426480.USD","LU0348827113.USD","09939","LU2476274308.USD","IBBQ","LU1720050803.USD","LU0348825331.USD","HK0000320264.USD","IE00B0JY6N72.USD","LU0463099449.HKD","LU0823426308.USD","BK1141","HK0000306685.HKD","BK4585","BK1583","LU0856984785.SGD","LU0128522744.USD","LU0588546209.SGD","LU1242518857.USD","BK1521","LU0359202008.SGD","LU3063872942.SGD","BK1610","LU0516423174.USD","01548","LU0052750758.USD","LU0128526141.USD","LU1688375341.USD","BK1576","BK1589","LU2476274720.SGD","LU2488822045.USD","LU0307460666.USD","BK1617","LU1794554557.SGD","KCAI","LU0708995583.HKD","LU1188198961.HKD","SG9999014674.SGD","02563","LU0029874061.USD","LU0327786744.USD","LU1242518931.SGD","02228","01672","LU0456846285.SGD","LU0828237510.HKD","LU1880383366.USD","LU0634319403.HKD","HK0000306701.USD","LU0456827905.SGD","02269","LU0051755006.USD","VXUS","06978","LU0029874905.USD","01477","SG9999002463.SGD","LU0348735423.USD","LU0417516902.SGD","LU2039709279.SGD","LU0181495838.USD","LU0228659784.USD","LU0320764243.SGD","LU0140636845.USD","LU0320764599.SGD","LU0516422952.EUR","LU0417516738.SGD","LU0540923850.HKD","LU0979878070.USD","LU0043850808.USD","LU0516423091.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675807291","title":"辛达克斯制药特发性肺纤维化临床试验失败，盘后股价暴跌34%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2675807291","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675807291?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 04:03","pubTimestamp":1791835411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IBBQ","MDTX","IBBJ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100229433","title":"再生元制药：Pasatru在第56至84周展现出持续疗效与一致性安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1100229433","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100229433?lang=zh_cn&edition=fundamental","pubTime":"2026-10-13 00:07","pubTimestamp":1791821228,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，Pasatru在用药第56周至第84周期间，持续显示出稳定的疗效，其安全性特征亦保持一贯。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2089984988.USD","LU0114720955.EUR","LU0109394709.USD","BBH","LU2468319806.SGD","LU0053666078.USD","LU0289739699.SGD","LU0823416689.USD","LU2023250504.SGD","BK4585","LU2362540622.SGD","IBBQ","LU2324357040.USD","TBXU","LU0889565916.HKD","LU0320765992.SGD","LU1974910355.USD","LU0882574055.USD","LU2362541273.HKD","LU1917777945.USD","LU2106854487.HKD","LU2362541513.USD","BK4588","REGN","IBB","LU0823434583.USD","LU0058720904.USD","LU0823434740.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674235808","title":"博瑞医药(688166.SH)：BGM0504片获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2674235808","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674235808?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 21:27","pubTimestamp":1791811676,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博瑞医药 发布公告，公司全资子公司博瑞制药(苏州)有限公司近日收到国家药品监督管理局签发的《药物临床试验批准通知书》，同意博瑞制药BGM0504片在成人2型糖尿病患者中开展临床试验。BGM0504片是BGM0504的口服剂型，其超重/肥胖适应症在中国和美国开展的I期临床研究已完成，目前中国正在开展II期临床研究，已完成全部参与者入组。截至公告披露日，全球尚无同类靶点口服剂型获批上市。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDTX","PSYK","BMED","688166","BK0239","IBBJ","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674808437","title":"微芯生物(688321.SH)：CS43158片获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2674808437","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674808437?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 21:21","pubTimestamp":1791811288,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微芯生物(688321.SH)发布公告，公司近日收到国家药品监督管理局签发的《药物临床试验批准通知书》，同意公司产品CS43158片开展急性髓系白血病的临床试验。CS43158是一款多靶点蛋白激酶抑制剂，可同时覆盖急性髓系白血病(AML)的驱动致癌通路与旁路激活耐药通路，兼具靶向原发驱动突变与克服继发耐药的双重作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBQ","PSYK","IBBJ","BK0239","688321","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674870087","title":"神州细胞：控股子公司SCT810注射液获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2674870087","media":"同花顺","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674870087?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 20:48","pubTimestamp":1791809280,"startTime":"0","endTime":"0","summary":"10月12日，神州细胞(688520.SH)公告称，公司控股子公司神州细胞工程有限公司收到国家药监局核准签发的《药物临床试验批准通知书》，同意其自主研发的SCT810注射液开展伴或不伴抑制物的中重 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261012/c680606793.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261012/c680606793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MDTX","PSYK","BMED","BK0239","IBBJ","IBBQ","688520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674342870","title":"纳微科技与智翔金泰签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2674342870","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674342870?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 20:32","pubTimestamp":1791808379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNY","MRNX","IBBQ","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674571877","title":"神州细胞：控股子公司SCT810注射液获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2674571877","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674571877?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 20:01","pubTimestamp":1791806518,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IBBQ","MDTX","IBBJ","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674720928","title":"微芯生物：CS43158片获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2674720928","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674720928?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 19:58","pubTimestamp":1791806304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","BMED","PSYK","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}